These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 659349

  • 21. [Antibiotic-induced diseases. Aminoglycoside-induced renal lesions].
    Gioannini P.
    Minerva Med; 1978 Dec 15; 69(61):4215-25. PubMed ID: 366465
    [No Abstract] [Full Text] [Related]

  • 22. Impact of aminoglycoside serum assays on clinical decisions and renal toxicity.
    Arroyo JC, Milligan WL, Davis J, Mitchell D.
    South Med J; 1986 Mar 15; 79(3):272-6. PubMed ID: 3513326
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Ototoxicity and nephrotoxicity of gentamicin and tobramycin].
    Andreu J, Bodet B, Garand G, Dabo B, Leroy G.
    Cah Anesthesiol; 1985 Oct 15; 33(6):515-21. PubMed ID: 4084845
    [No Abstract] [Full Text] [Related]

  • 26. Aminoglycoside nephrotoxicity and renal function status.
    Bottemiller BL.
    Am J Hosp Pharm; 1986 Jan 15; 43(1):66, 68. PubMed ID: 3953586
    [No Abstract] [Full Text] [Related]

  • 27. Renal and auditory toxicity of high-dose, prolonged therapy with gentamicin and tobramycin in pseudomonas endocarditis.
    Tablan OC, Reyes MP, Rintelmann WF, Lerner AM.
    J Infect Dis; 1984 Feb 15; 149(2):257-63. PubMed ID: 6421944
    [Abstract] [Full Text] [Related]

  • 28. [Which factors are increasing the nephrotoxicity of aminoglucoside antibiotics?].
    Stahlmann R, Lode H.
    Dtsch Med Wochenschr; 1986 Sep 12; 111(37):1409-14. PubMed ID: 3527647
    [No Abstract] [Full Text] [Related]

  • 29. Tobramycin and gentamicin are equally safe for neonates: results of a double-blind randomized trial with quantitative assessment of renal function.
    Itsarayoungyuen S, Riff L, Schauf V, Hamilton L, Otrembiak J, Vidyasagar D.
    Pediatr Pharmacol (New York); 1982 Sep 12; 2(2):143-55. PubMed ID: 12760406
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Risk factors for nephrotoxicity in patients treated with aminoglycosides.
    Moore RD, Smith CR, Lipsky JJ, Mellits ED, Lietman PS.
    Ann Intern Med; 1984 Mar 12; 100(3):352-7. PubMed ID: 6364908
    [Abstract] [Full Text] [Related]

  • 33. Clinical assessment of a published model to predict aminoglycoside-induced nephrotoxicity.
    Garrison MW, Rotschafer JC.
    Ther Drug Monit; 1989 Mar 12; 11(2):171-5. PubMed ID: 2718222
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Comparative effects of gentamicin and tobramycin on excretion of N-acetyl-beta-D-glucosaminidase.
    Donta ST, Lembke LA.
    Antimicrob Agents Chemother; 1985 Oct 12; 28(4):500-3. PubMed ID: 4073872
    [Abstract] [Full Text] [Related]

  • 38. Gentamicin and tobramycin in patients with various infections--concentrations in serum and urinary excretion.
    Kahlmeter G, Hallberg T, Kamme C.
    J Antimicrob Chemother; 1978 May 12; 4 Suppl A():37-45. PubMed ID: 659348
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.